On cost effectiveness analysis and fairness: Normalizing control of and resistance to NICE technology appraisals
Abstract
This study examines National Institute for Health and Care Excellence's (NICE) application of cost effectiveness analysis (CEA) for normalizing patients’ access to newly licensed health technologies. Drawing upon evidence from the appraisal of four drugs developed for a rare form of cancer, this study demonstrates that the discourse of CEA provided a medium whereby contradicting ideologies of fairness were contested and resistance was provoked....
Paper Details
Title
On cost effectiveness analysis and fairness: Normalizing control of and resistance to NICE technology appraisals
Published Date
May 8, 2020
Volume
37
Issue
1
Pages
37 - 53
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History